Access to Breast Cancer Diagnosis Act of 2021

Access to Breast Cancer Diagnosis Act of 2021

This bill prohibits private health insurance plans from imposing higher cost-sharing requirements on breast cancer diagnostic examinations than initial breast cancer screening examinations. Diagnostic examinations are generally required after an initial screening detects an abnormality and typically require additional mammogram images (e.g., x-rays).

Bill 117 HR 5769, also known as the Access to Breast Cancer Diagnosis Act of 2021, aims to improve access to breast cancer screening and diagnosis for women across the United States. The bill focuses on increasing funding for mammograms and other diagnostic tests, as well as ensuring that women have access to timely and accurate information about their breast health.

One key provision of the bill is the establishment of a grant program to help healthcare providers offer free or low-cost mammograms to women who may not otherwise be able to afford them. This program would also provide funding for outreach and education efforts to raise awareness about the importance of early detection and screening for breast cancer.

Additionally, the bill includes measures to improve the quality and accuracy of breast cancer screenings, such as requiring healthcare providers to follow best practices for interpreting mammograms and other diagnostic tests. The bill also calls for increased research funding to support the development of new and improved screening technologies. Overall, the Access to Breast Cancer Diagnosis Act of 2021 seeks to address disparities in access to breast cancer screening and diagnosis, particularly among underserved communities. By increasing funding, improving quality standards, and promoting education and outreach efforts, the bill aims to ensure that all women have the opportunity to receive timely and accurate information about their breast health.